Mumbai: US President Donald Trump has announced that from October 1, every branded and patented medicine imported into the United States will attract a 100 percent tariff. This means the price of such medicines will effectively double if the company producing them doesn’t have a manufacturing unit inside the US. The move is seen as an attempt to pressure global pharma companies into setting up production facilities in America instead of importing high-value medicines from abroad.

Donald J. Trump Truth Social Post 07:24 PM EST 09/25/25 pic.twitter.com/n6bUa7aY00 — Commentary Donald J. Trump Posts From Truth Social (@TrumpDailyPosts) September 26, 2025

Who Will Be Hit the Hardest?

This decision is primarily aimed at innovator pharmaceutical companies — the ones that develop and sell n

See Full Page